Loading…
Structure-functional implications of longevity protein p66Shc in health and disease
•P66Shc acts as a dual player in cell growth, mediating both cell proliferation and apoptosis.•P66Shc induced mitochondrial dysfunction and over production of ROS promotes development of neuro and metabolic ageing diseases.•Abnormalities in p66Shc expression are associated with metastasis and tumor...
Saved in:
Published in: | Ageing research reviews 2020-11, Vol.63, p.101139-101139, Article 101139 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •P66Shc acts as a dual player in cell growth, mediating both cell proliferation and apoptosis.•P66Shc induced mitochondrial dysfunction and over production of ROS promotes development of neuro and metabolic ageing diseases.•Abnormalities in p66Shc expression are associated with metastasis and tumor progression.•Chemotherapeutic targeting of p66Shc/ROS pathway can be used to prevent chronic age-related diseases.
ShcA (Src homologous- collagen homologue), family of adapter proteins, consists of three isoforms which integrate and transduce external stimuli to different signaling networks. ShcA family consists of p46Shc, p52Shc and p66Shc isoforms, characterized by having multiple protein-lipid and protein-protein interaction domains implying their functional diversity. Among the three isoforms p66Shc is structurally different containing an additional CH2 domain which attributes to its dual functionality in cell growth, mediating both cell proliferation and apoptosis. Besides, p66Shc is also involved in different biological processes including reactive oxygen species (ROS) production, cell migration, ageing, cytoskeletal reorganization and cell adhesion. Moreover, the interplay between p66Shc and ROS is implicated in the pathology of various dreadful diseases. Accordingly, here we discuss the recent structural aspects of all ShcA adaptor proteins but are highlighting the case of p66Shc as model isoform. Furthermore, this review insights the role of p66Shc in progression of chronic age-related diseases like neuro diseases, metabolic disorders (non-alcoholic fatty liver, obesity, diabetes, cardiovascular diseases, vascular endothelial dysfunction) and cancer in relation to ROS. We finally conclude that p66Shc might act as a valuable biomarker for the prognosis of these diseases and could be used as a potential therapeutic target. |
---|---|
ISSN: | 1568-1637 1872-9649 |
DOI: | 10.1016/j.arr.2020.101139 |